Candesartan HCT Zentiva 32/12.5mg, Tabletten - 28 Swissmedic Key 62321017 Registration Holder Helvepharm AG Name Candesartan HCT Zentiva 32/12.5mg, Tabletten Date of registration 30.01.2012 Original/Generic Generic Introduction of Sequence 02.12.2013 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 28 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 11.01 Limitation No Deductible 10 % Consumer price 28.35 Feedback FB GTIN 7680623210173 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 32 mg, hydrochlorothiazidum 12.5 mg, mannitolum 138.4 mg, maydis amylum, copovidonum, glycerolum 13 mg, magnesii stearas, E 172 (flavum), pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose additional_information (Flavum) Copovidonum E 172 color. Glycerol 13 mg Magnesii Stearas Mannitol 138.4 mg Maydis Amylum Pro Compresso
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
